Cargando…

Qige Huxin Formula Attenuates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Protecting Intestinal Integrity

BACKGROUND: The composition and metabolic activities of gut microbiota are strongly interconnected with cardiac fibrosis (CF) and heart failure (HF). Qige Huxin formula (QHF), a traditional Chinese medicine (TCM) formulation originating from a classical Fangji Huangqi decoction, has been widely used...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Lipeng, Du, Xuqin, Zuo, Biao, Hu, Jinyuan, Cao, Wenfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328975/
https://www.ncbi.nlm.nih.gov/pubmed/35911163
http://dx.doi.org/10.1155/2022/2894659
_version_ 1784757836483395584
author Shi, Lipeng
Du, Xuqin
Zuo, Biao
Hu, Jinyuan
Cao, Wenfu
author_facet Shi, Lipeng
Du, Xuqin
Zuo, Biao
Hu, Jinyuan
Cao, Wenfu
author_sort Shi, Lipeng
collection PubMed
description BACKGROUND: The composition and metabolic activities of gut microbiota are strongly interconnected with cardiac fibrosis (CF) and heart failure (HF). Qige Huxin formula (QHF), a traditional Chinese medicine (TCM) formulation originating from a classical Fangji Huangqi decoction, has been widely used to clinically treat HF for decades. However, it is still unclear whether QHF alleviates CF by modulating gut microbiota and intestinal integrity. PURPOSE: This study aimed to investigate the cardioprotective effects of QHF in isoprenaline-induced CF through modulating gut microbiota and intestinal integrity. METHODS: Fifty mice were randomly divided into five groups after one week of acclimatization feeding: control group, model group, 2.56 g/kg/d group (low-dose QHF), 5.12 g/kg/d group (high-dose QHF), and meto group (15 mg/kg/d). The CF model was established by subcutaneously injecting the mice with isoprenaline (10 mg/kg/d for 14 days), followed by QHF treatment. The heart volume, cardiac weight index (CWI), serum myocardial enzymes, serum inflammatory cytokines, serum lipopolysaccharide, histopathology of the heart and colon tissues, ZO-1, and occludin of colon tissues were then measured. Fecal samples from mice were analyzed using 16S rRNA sequencing. RESULTS: QHF treatment significantly reduced heart volume, CWI, and serum CK and CK-MB levels, attenuated cardiac histopathological alterations, and alleviated CF. QHF treatment also downregulated TNF-α, IL-1β, and IL-6 in serum. Moreover, QHF treatment decreased the serum level of lipopolysaccharide and maintained intestinal integrity by upregulating ZO-1 and occludin. The 16S rRNA microbiota analysis revealed that QHF treatment increased the relative abundance of Marvinbryantia and Phascolarctobacterium. CONCLUSIONS: QHF treatment exerts cardioprotective effects through modulating gut microbiota, protecting intestinal integrity, and alleviating inflammation. This study shows that gut microbiota may enhance heart-gut interaction.
format Online
Article
Text
id pubmed-9328975
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-93289752022-07-28 Qige Huxin Formula Attenuates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Protecting Intestinal Integrity Shi, Lipeng Du, Xuqin Zuo, Biao Hu, Jinyuan Cao, Wenfu Evid Based Complement Alternat Med Research Article BACKGROUND: The composition and metabolic activities of gut microbiota are strongly interconnected with cardiac fibrosis (CF) and heart failure (HF). Qige Huxin formula (QHF), a traditional Chinese medicine (TCM) formulation originating from a classical Fangji Huangqi decoction, has been widely used to clinically treat HF for decades. However, it is still unclear whether QHF alleviates CF by modulating gut microbiota and intestinal integrity. PURPOSE: This study aimed to investigate the cardioprotective effects of QHF in isoprenaline-induced CF through modulating gut microbiota and intestinal integrity. METHODS: Fifty mice were randomly divided into five groups after one week of acclimatization feeding: control group, model group, 2.56 g/kg/d group (low-dose QHF), 5.12 g/kg/d group (high-dose QHF), and meto group (15 mg/kg/d). The CF model was established by subcutaneously injecting the mice with isoprenaline (10 mg/kg/d for 14 days), followed by QHF treatment. The heart volume, cardiac weight index (CWI), serum myocardial enzymes, serum inflammatory cytokines, serum lipopolysaccharide, histopathology of the heart and colon tissues, ZO-1, and occludin of colon tissues were then measured. Fecal samples from mice were analyzed using 16S rRNA sequencing. RESULTS: QHF treatment significantly reduced heart volume, CWI, and serum CK and CK-MB levels, attenuated cardiac histopathological alterations, and alleviated CF. QHF treatment also downregulated TNF-α, IL-1β, and IL-6 in serum. Moreover, QHF treatment decreased the serum level of lipopolysaccharide and maintained intestinal integrity by upregulating ZO-1 and occludin. The 16S rRNA microbiota analysis revealed that QHF treatment increased the relative abundance of Marvinbryantia and Phascolarctobacterium. CONCLUSIONS: QHF treatment exerts cardioprotective effects through modulating gut microbiota, protecting intestinal integrity, and alleviating inflammation. This study shows that gut microbiota may enhance heart-gut interaction. Hindawi 2022-07-20 /pmc/articles/PMC9328975/ /pubmed/35911163 http://dx.doi.org/10.1155/2022/2894659 Text en Copyright © 2022 Lipeng Shi et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shi, Lipeng
Du, Xuqin
Zuo, Biao
Hu, Jinyuan
Cao, Wenfu
Qige Huxin Formula Attenuates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Protecting Intestinal Integrity
title Qige Huxin Formula Attenuates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Protecting Intestinal Integrity
title_full Qige Huxin Formula Attenuates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Protecting Intestinal Integrity
title_fullStr Qige Huxin Formula Attenuates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Protecting Intestinal Integrity
title_full_unstemmed Qige Huxin Formula Attenuates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Protecting Intestinal Integrity
title_short Qige Huxin Formula Attenuates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Protecting Intestinal Integrity
title_sort qige huxin formula attenuates isoprenaline-induced cardiac fibrosis in mice via modulating gut microbiota and protecting intestinal integrity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328975/
https://www.ncbi.nlm.nih.gov/pubmed/35911163
http://dx.doi.org/10.1155/2022/2894659
work_keys_str_mv AT shilipeng qigehuxinformulaattenuatesisoprenalineinducedcardiacfibrosisinmiceviamodulatinggutmicrobiotaandprotectingintestinalintegrity
AT duxuqin qigehuxinformulaattenuatesisoprenalineinducedcardiacfibrosisinmiceviamodulatinggutmicrobiotaandprotectingintestinalintegrity
AT zuobiao qigehuxinformulaattenuatesisoprenalineinducedcardiacfibrosisinmiceviamodulatinggutmicrobiotaandprotectingintestinalintegrity
AT hujinyuan qigehuxinformulaattenuatesisoprenalineinducedcardiacfibrosisinmiceviamodulatinggutmicrobiotaandprotectingintestinalintegrity
AT caowenfu qigehuxinformulaattenuatesisoprenalineinducedcardiacfibrosisinmiceviamodulatinggutmicrobiotaandprotectingintestinalintegrity